Wednesday, July 8, 2026

pharma · Focal Segmental Glomerulosclerosis · Immunoglobulin A Nephropathy (IgAN) · TVTX

Travere Therapeutics

News and analysis for Travere Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

3611 Valley Centre Dr, Suite 300, San Diego, California 92130, US HQ
2020 Founded
506 Employees
Public company Type
TVTX · NYSE Ticker
Company details
Status
Public
HQ
3611 Valley Centre Dr, Suite 300, San Diego, California 92130, US
Founded
2020
Employees
506
Programs
13
Drugs
9
Patents
1
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Travere Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Travere Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Travere Therapeutics yet.

Back to company overview →